Advancing Cell Therapy for Neurodegenerative Diseases

The authors examine how the ability to generate diverse central nervous system cell types from stem cells, along with a deeper understanding of cell-type-specific functions and pathology, is advancing preclinical development of cell products for the treatment of neurodegenerative diseases.